Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns

Maarten Nierop, Boris Galjart, Diederik Höppener, Eric Stok, Robert Coebergh van den Braak, PB Vermeulen, DJ Grunhagen, Kees Verhoef*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)
27 Downloads (Pure)


The majority of patients recur after resection of colorectal liver metastases (CRLM). Patients with CRLM displaying a desmoplastic histopathological growth pattern (dHGP) have a better prognosis and lower probability of recurrence than patients with non-dHGP CRLM. The current study evaluates the impact of HGP type on the pattern and treatment of recurrences after first resection of CRLM. A retrospective cohort study was performed, including patients with known HGP type after complete resection of CRLM. All patients were treated between 2000 and 2015. The HGP was determined on the CRLM resected at first partial hepatectomy. The prognostic value of HGPs, in terms of survival outcome, in the current patient cohort were previously published. In total 690 patients were included, of which 492 (71%) developed recurrent disease. CRLM displaying dHGP were observed in 103 patients (21%). Amongst patients with dHGP CRLM diagnosed with recurrent disease, more liver-limited recurrences were seen (43% vs. 31%, p = 0.030), whereas patients with non-dHGP more often recurred at multiple locations (34% vs. 19%, p = 0.005). Patients with dHGP CRLM were more likely to undergo curatively intended local treatment for recurrent disease (adjusted odds ratio: 2.37; 95% confidence interval (CI) [1.46-3.84]; p < 0.001) compared to patients with non-dHGP. The present study demonstrates that liver-limited disease recurrence after complete resection of CRLM is more often seen in patients with dHGP, whereas patients with non-dHGP more frequently experience multi-organ recurrence. Recurrences in patients with dHGP at first CRLM resection are more likely to be salvageable by local treatment modalities, but no prognostic impact of HGPs after salvage therapy for recurrent disease was found.

Original languageEnglish
Pages (from-to)109-118
Number of pages10
JournalClinical & Experimental Metastasis
Issue number2
Early online date6 Mar 2019
Publication statusPublished - 15 Apr 2019

Research programs

  • EMC MM-03-47-11


Dive into the research topics of 'Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns'. Together they form a unique fingerprint.

Cite this